Moreover, we are presenting hereby the first human translatable evidence that CNS-targeted neuron-specific, however, subtype general chemogenetic stimulation can be similarly effective in reducing food intake than the currently most effective GLP-1 agonist pharmacological therapy available on the market in obesity indication25. This evidence concerns the gene GCG and obesity disorder.